IWC
LFCR icon

Integrated Wealth Concepts’s Lifecore Biomedical LFCR Stock Holding History

Integrated Wealth Concepts’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13K Buy
+215
New +$1.08K ﹤0.01% 5504

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Integrated Wealth Concepts's LFCR Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 215 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #5504 among its holdings.

99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Integrated Wealth Concepts held 215 shares of Lifecore Biomedical worth $1.13K as of Q2 2026.
  • Lifecore Biomedical was a new Integrated Wealth Concepts position in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5504 holding.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.